Moshfeghi, Darius M <br/><br/>
Retinopathy of prematurity in the time of bevacizumab: incorporating the BEAT-ROP results into clinical practice.  [electronic resource] 

 -  Ophthalmology  Jul 2011 
 - 1227-8 p.  digital 
<br/><br/> Publication Type: Editorial 
<br/><br/><label>ISSN: </label>1549-4713 
<br/><br/><label>Standard No.: </label>10.1016/j.ophtha.2011.04.028  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--therapeutic use<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Bevacizumab<br/>Clinical Trials, Phase II as Topic<br/>Diffusion of Innovation<br/>Humans<br/>Infant, Newborn<br/>Multicenter Studies as Topic<br/>Neovascularization, Pathologic--etiology<br/>Prospective Studies<br/>Randomized Controlled Trials as Topic<br/>Retinopathy of Prematurity--complications